Results for:(113 found)
Dec 19, 2012 9:26AM on Top StocksBy Stock Traders Daily

With the help of an imaging agent, the pharma is pursuing what it hopes will be a blockbuster drug.

Dec 17, 2012 11:46AM on Top StocksBy Benzinga

Look to this pair of underperformers to make a potential positive shift in the new year.

Dec 13, 2012 1:12PM on Top StocksBy InvestorPlace

Some pharma stocks could get a shot in the arm as CDC issues early warning.

Nov 27, 2012 4:43PM on Top StocksBy Minyanville.com

New data are significant as the biotech company moves closer to filing for approval of Sofosbuvir next year.

Nov 20, 2012 1:24PM on Top StocksBy MSN Money Partner

Research in Motion is upgraded to 'hold,' and Intel is downgraded to 'neutral.'

Nov 8, 2012 7:30AM on Top StocksBy Benzinga

Interest rate decisions are expected today from the European Central Bank and Bank of England.

Nov 7, 2012 10:17PM on Top StocksBy Gene Marcial

The market's tumble Wednesday following the president's reelection offers a fresh and real chance to ride the bull market.

Oct 31, 2012 10:38AM on Top StocksBy InvestorPlace

The revenue in question seems too small to make a difference.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

TOP STOCKS

Goldman loses its grip on stock-trading lead

The company is scrambling to protect its equities arm, which could face declining volume and revenue as competitors close the gap.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More